Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo

Nature Medicine volume 2, pages 567–573 (1996)Cite this article

Abstract

Cytosine arabinoside (ara–C) is a cytidine analog that incorporates into replicating DNA and induces lethal DNA strand breaks. Although ara–C is a potent antitumor agent for hematologic malignancies, it has only minimal activity against most solid tumors. The rate–limiting step in intracellular ara–C activation is phosphorylation of the prodrug by deoxycytidine kinase (dCK). The present results demonstrate that both retroviral and adenoviral vector–mediated transduction of the dCK cDNA results in marked sensitization of glioma cell lines to the cytotoxic effects of ara–C in vitro. We also demonstrate that ara–C treatment of established intradermal and intracerebral gliomas transduced with dCK results in significant antitumor effects in vivo. These data suggest that viral vector transduction of the dCK gene followed by treatment with ara–C represents a new chemosensitization strategy for cancer gene therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Anderson, W.F. Human gene therapy. Science 256, 808–813 (1992).

    Article  CAS  PubMed  Google Scholar 

  2. Mullen, C.A., Kilstrup, M. & Blaese, R.M. Transfer of the bacterial gene for cyto-sine deaminase to mammalian Cells confers lethal sensitivity to 5-fluorocyto-sine: A negative selection system. Proc. Natl. Acad. Sci. USA 89, 33–37 (1992).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Culver, K.W. et al. In vivo gene transfer with retroviral-vector producer Cells for treatment of experimental brain tumors. Science 256, 1550–1552 (1992).

    Article  CAS  PubMed  Google Scholar 

  4. Moolten, F.L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276–5281 (1986).

    CAS  PubMed  Google Scholar 

  5. Ellison, R.R. et al. Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults. Blood 32, 507–523 (1968).

    CAS  PubMed  Google Scholar 

  6. Cadman, E., Farber, L., Berd, D. & Bertino, J. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites. Cancer Treat. Rep. 61, 1109–1116 (1977).

    CAS  PubMed  Google Scholar 

  7. Graham, F.L. & Whitmore, G.F. Studies in mouse L-Cells on the incorporation of 1-β-D-arabinofuranosylcytosine into DNA and on inhibition of DNA poly-merase by 1-β-D-arabinofuranosylcytosine-5′-triphosphate. Cancer Res. 30, 2636–2644 (1970).

    CAS  PubMed  Google Scholar 

  8. Kufe, W.D. et al. Correlation of cytotoxicity with incorporation of ara-C into DNA. J. Biol. Chem. 225, 8997–9000 (1980).

    Google Scholar 

  9. Kufe, D., Spriggs, D., Egan, E.M. & Munroe, D. Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic Cells. Blood 64, 54–58 (1984).

    CAS  PubMed  Google Scholar 

  10. Early, A.P., Preisler, H.D., Slocum, H. & Rustum, Y.M. A pilot study of high dose 1-1-β-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: Clinical response and pharmacology. Cancer Res. 42, 1587–1594 (1982).

    CAS  PubMed  Google Scholar 

  11. Colly, L.P. & Van Bekkum, D.W. A recommendation for high dose Ara-C treatment based on studies on a slow growing leukemia model (BNML). Med. Pediatr. Oncol. 209 (suppl. 1), 209–220 (1982).

    Article  Google Scholar 

  12. Colly, L.P., Peters, W.G. & Willemze, R. Effect of the interval between high dose 1-β-D-arabinofuranosylcytosine injections on leukemic Cell load, intestinal toxicity, and normal hematopoietic stem Cells in a rat model for acute myelogenous leukemia. Cancer Res, 46, 3825–3827 (1986).

    CAS  PubMed  Google Scholar 

  13. Colly, L.P., van Bekkum, D.W. & Hagenbeek, A. Cell kinetic studies after high dose Ara-C and adriamycin treatment in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia. Leak. Res. 8, 945–952 (1984).

    Article  CAS  Google Scholar 

  14. Vaughan, W.P. & Burke, P.J. Development of a Cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the Cell cycle-specific drug 1-β-D-arabinofuranosylcytosine in a rat model. Cancer Res. 43, 2005–2009 (1983).

    CAS  PubMed  Google Scholar 

  15. Wiley, J.S., Jones, S.P., Sawyer, W.H. & Paterson, A.R.D. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. J. Clin. Invest. 69, 479–489 (1982).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fram, R.J., Egan, E.M. & Kufe, D.W. Accumulation of leukemic Cell DNA strand breaks with adriamycin and cytosine arabinoside. Leak. Res. 7, 243–249 (1983).

    Article  CAS  Google Scholar 

  17. Kufe, D.W., Munroe, D., Herrick, D., Egan, E. & Spriggs, D. Effects of l-(5-D-ara-binofuranosylcytosine incorporation on eukaryotic DNA template function. Mol. Pharmacol. 26, 128–134 (1984).

    CAS  Google Scholar 

  18. Mikita, T. & Beardsley, G.P. Functional consequences of the arabinosylcytosine structural lesion in DNA. Biochemistry 27, 4698–4705 (1988).

    Article  CAS  PubMed  Google Scholar 

  19. Ohno, Y., Spriggs, D., Matsukage, A., Ohno, T. & Kufe, D. Effects of 1-β-D-arabi-nofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase β1. Cancer Res. 48, 1494–1498 (1988).

    CAS  PubMed  Google Scholar 

  20. Plagemann, P.G.W., Marz, R. & Wohlhueter, R.M. Transport and metabolism of deoxycytidine and 1-β-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma Cells, relationship to phosphorylation and regulation of triphos-phate synthesis. Cancer Res. 38, 978–989 (1978).

    CAS  PubMed  Google Scholar 

  21. Engelhardt, J.F. et al. Direct gene transfer of human CFTR into human bronchial epitheria of xenographs with El-deleted adenoviruses. Nature Genet. 4, 27–34 (1993).

    Article  CAS  PubMed  Google Scholar 

  22. Engelhardt, J.F., Ye, X., Doranz, B. & Wilson, J.M. Ablation of E2A in recombi-nant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver Proc. Natl. Acad. Sci. USA 91, 6196–6200 (1994).

    Article  CAS  Google Scholar 

  23. Tapscott, S.J. et al. Gene therapy of tat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc. Natl. Acad. Sci. USA 91, 8185–8189 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Chottiner, E.G. et al. Cloning and expression of human deoxycytidine kinase cDNA. Proc. Natl. Acad. Sci. USA 88, 1531–1535 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Housey, G.M. et al. Overproduction of protein kinase C causes disordered growth control in rat fibroblast. Cell 52, 343–354 (1988).

    Article  CAS  PubMed  Google Scholar 

  26. Chirgwin, J.M., Pryzbyla, A.E., MacDonald, R.J. & Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).

    Article  CAS  PubMed  Google Scholar 

  27. Manome, Y., Datta, R. & Fine, H.A. Early response gene induction following DNA damage in astrocytoma Cell lines. Biochem. Pharmacol. 45, 1677–1684 (1993).

    Article  CAS  PubMed  Google Scholar 

  28. Manome, Y., Abe, M., Hagen, M.F., Fine, H.A. & Kufe, D.W. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer Cells to ganciclovir. Cancer Res. 54, 5408–5413 (1994).

    CAS  PubMed  Google Scholar 

  29. Freeman, S.M. et al. The “bystander effect”: Tumor regression with a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274–5283 (1993).

    CAS  PubMed  Google Scholar 

  30. Major, P.P., Egan, E.M., Herrick, D.J. & Kufe, D.W. Effect of ara-C incorporation on deoxyribonucleic acid synthesis in Cells. Biochem. Pharmacol. 31, 2937–2940 (1982).

    Article  CAS  PubMed  Google Scholar 

  31. Major, P.P., Egan, E.M., Beardsley, G.P., Minden, M.D. & Kufe, D.W. Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcy-tosine into DNA. Proc. Natl. Acad. Sci. USA 78, 3235–3239 (1981).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kobayashi, N., Allen, N., Clendenon, N.R. & Ko, L.-W. An improved rat brain-tumor model. J Neurosurg. 53, 808–815 (1980).

    Article  CAS  PubMed  Google Scholar 

  33. Graham, F.L., Smiley, J., Russel, W.C. & Nairn, R. Characteristics of a human Cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59–72 (1977).

    Article  CAS  PubMed  Google Scholar 

  34. McGrory, W.J., Bautista, D.S. & Graham, F.L. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163, 614–617 (1988).

    Article  CAS  PubMed  Google Scholar 

  35. Graham, F.L. & Prevec, L. Manipulation of adenovirus vectors. in Methods in Molecular Biology (ed. Murray, E.J.) 109–128 (Humana Press Inc., Clifton, New Jersey, 1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cancer Pharmacology, Dana Farber Cancer Institute, Room 1560, 44 Binney Street, Boston, Massachusetts, 02115, USA

    Yoshinobu Manome, Yonghe Dong, Toshihide Tanaka, Donald W. Kufe & Howard A. Fine

  2. Division of Neurology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, 02115, USA

    Patrick Y. Wen

  3. University of North Carolina Medical School, Chapel Hill, North Carolina, 27599, USA

    Beverly S. Mitchell

Authors
  1. Yoshinobu Manome
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick Y. Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yonghe Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshihide Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Beverly S. Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Donald W. Kufe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Howard A. Fine
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manome, Y., Wen, P., Dong, Y. et al. Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med 2, 567–573 (1996). https://doi.org/10.1038/nm0596-567

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0596-567

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing